Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum. [electronic resource]
Producer: 20190930Description: 17-24 p. digitalISSN:- 1435-1463
- Animals
- Corpus Striatum -- drug effects
- Cyclic ADP-Ribose -- metabolism
- Dopamine -- pharmacology
- Dopamine Agonists -- pharmacology
- Dose-Response Relationship, Drug
- Male
- Mice
- Mice, Inbred ICR
- Receptors, Dopamine -- metabolism
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.